Mounjaro KwikPen contains tirzepatide, a prescription-only medicine used for weight management in eligible adults alongside a reduced-calorie diet and increased physical activity. It works by regulating appetite, helping reduce hunger and increasing feelings of fullness.
Key Features
- Contains tirzepatide, a dual GIP and GLP-1 receptor agonist.
- Available in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.
- Administered as a once-weekly injection.
- Each KwikPen contains four weekly doses.
- The prescribed strength may be adjusted gradually according to clinical response and tolerability.
- Injection needles are not included in the manufacturer’s pack.
Who Is This Product For?
Mounjaro is used for weight management in adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition. Treatment requires an appropriate clinical assessment and a valid prescription. Chrystalls Connect provides its weight-loss service to eligible adults aged 18 years and over.
How to Use
Mounjaro is injected once weekly under the skin of the abdomen, thigh or upper arm. It can be administered at any time of day, with or without food.
The usual starting dose is 2.5mg once weekly for four weeks, followed by 5mg once weekly. If clinically appropriate, the prescriber may increase the dose in 2.5mg increments after at least four weeks at the current dose.
- 2.5mg – Usual starting dose for the first four weeks.
- 5mg – Usually prescribed after the initial four weeks.
- 7.5mg – Further dose escalation when prescribed.
- 10mg – Further dose escalation or maintenance when prescribed.
- 12.5mg – Further dose escalation when prescribed.
- 15mg – Maximum recommended weekly dose.
The recommended adult maintenance doses are 5mg, 10mg and 15mg once weekly. Not every patient requires the highest dose. Always follow your prescriber’s instructions and do not change your dose without medical advice.
Storage & Handling
- Before first use, store in a refrigerator at 2°C–8°C.
- Do not freeze or use if the medicine has been frozen.
- After first use, the pen may be stored at temperatures not exceeding 30°C for up to 30 days, after which it must be discarded.
- Use a new compatible needle for each injection.
- Do not attempt to extract or use any medicine remaining after the four prescribed doses.
- Keep out of the sight and reach of children.
Possible Side Effects
Common side effects include nausea, vomiting, diarrhoea, constipation, indigestion and abdominal discomfort. These may be more noticeable when starting treatment or increasing the dose.
Vomiting and diarrhoea can cause dehydration. Seek immediate medical attention for severe, persistent abdominal pain, which may indicate pancreatitis, or symptoms of a serious allergic reaction.
Warnings & Precautions
- Do not use if allergic to tirzepatide or any other ingredient.
- Mounjaro should not be used during pregnancy. Discuss breastfeeding with your prescriber before using the medicine.
- Inform your prescriber if you have a history of pancreatitis, severe digestive problems or diabetic eye disease.
- Tell your prescriber if you take insulin or sulfonylureas, as these may increase the risk of low blood sugar.
- Patients using oral contraceptives should discuss additional barrier contraception or switching to a non-oral method for four weeks after starting treatment and four weeks after each dose increase.
- Inform your healthcare team before surgery or procedures involving anaesthesia.
- Tell your prescriber about all other medicines you take.
Important Information
Mounjaro is a prescription-only medicine. Supply through Chrystalls Connect requires a completed weight-loss consultation, a valid prescription and pharmacist approval.
Existing patients must provide their Patient ID and relevant treatment information so their prescription and requested strength can be checked against pharmacy records. Orders remain subject to clinical verification and stock availability.
Patient Information Leaflet
Always read the manufacturer’s patient information leaflet and instructions for use before administering Mounjaro KwikPen.


